Clinical Trials Search Results

1.

Radiation Therapy with or without Combination Chemotherapy or Pazopanib Hydrochloride before Surgery in Treating Patients with Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Status: Active
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 and over
Trial IDs: ARST1321, NCI-2014-01340, NCT02180867

2.

Image-Guided Intensity-Modulated Proton or Photon Beam Radiation Therapy with Boost in Treating Patients with Primary or Locally Recurrent Soft Tissue Sarcoma

Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-100, NCI-2012-01931, NCT01659203

3.

Talimogene Laherparepvec and Preoperative Radiation Therapy in Treating Patients with Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed by Surgery

Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201504731, NCI-2015-01193, 20139075, NCT02453191

4.

Proton Beam Radiation Therapy in Treating Younger Patients with Bone or Non-rhabdomyosarcoma Soft Tissue Sarcomas

Status: Active
Phase: Phase II
Type: Treatment
Age: 30 and under
Trial IDs: 05-326, NCI-2012-00673, NCT00592293

5.

Proton Beam Radiation Therapy in Treating Patients with Previously Untreated Childhood Rhabdomyosarcoma

Status: Active
Phase: Phase II
Type: Treatment
Age: 21 and under
Trial IDs: 04-188, NCI-2011-03349, NCT00592592

6.

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients with High-Risk Stage IIB-IV Soft Tissue Sarcoma

Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: IRB00009464, NCI-2013-02414, NCT02050919

7.

Doxorubicin Hydrochloride, Dexrazoxane Hydrochloride, and Olaratumab in Treating Patients with Advanced or Metastatic Soft Tissue Sarcoma That Cannot Be Removed by Surgery

Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201510049, NCI-2015-01777, NCT02584309

8.

Hypofractionated Radiation for Preoperative Treatment of Patients with Sarcoma

Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-001657, NCI-2016-00202, Sarcoma Hypofractionated, NCT02701153

9.

Talimogene Laherparepvec and Radiation Therapy in Treating Patients with Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 10056, NCI-2016-01461, MC1678, NCT02923778

10.

Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 and over
Trial IDs: 09-090, NCI-2010-01242, NCT01099644

11.

A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15840, NCI-2016-01274, 2015-005018-31, I5B-MC-JGDM, NCT02783599

12.

GL-ONC1 with or without Eculizumab in Treating Patients with Solid Organ Cancers before Surgery

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GL-ONC1-011, NCI-2016-01782, NCT02714374

13.

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer

Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778

14.

Recombinant Interferon Gamma in Treating Patients with Soft Tissue Sarcoma

Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2705.00, NCI-2013-01779, 2705, NCT01957709

Clinical Trials Search Results

Results 1-14 of 14 for your search: